In the T2DM subgroup, there was no significant difference in the usage of angiotensin receptor blockers/angiotensin converting enzyme inhibitor (ARB/ACEI) between the two groups, while the frequency of usage about other drugs was significantly higher in the CAD group (Table 1 and Table 2). The gene discussed is ACE; the disease is type 2 diabetes mellitus.